C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61P 37/02 (2006.01) C07K 14/705 (2006.01) C07K 14/715 (2006.01) C07K 14/725 (2006.01) C07K 16/00 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/12 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2110518
The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.
Brady William
Damle Nitin K.
Ledbetter Jeffrey A.
Linsley Peter S.
Bristol-Myers Squibb Company
Cassan Maclean
LandOfFree
Ctla4 receptor, fusion proteins containing it and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ctla4 receptor, fusion proteins containing it and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ctla4 receptor, fusion proteins containing it and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2085876